Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution

Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial

Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care

Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis

The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline

Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy

The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process

Gilead posts solid Q1 2026 growth & raises full-year outlook on HIV momentum

Mankind’s Rajeev Juneja contributes Rs. 9.17 crore to National Defence Fund

This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces

AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management

Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure

Even Hospital partners with Canara Surgicals to advance minimally invasive laser surgeries

The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties

Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics

The two companies will establish a joint Center of Excellence (CoE) in Bengaluru